Edit

Entrepreneurs Fund

https://entrepreneursfund.com
Last activity: 21.04.2021
Probably Closed
Invests in categories: CleanTechContentDevelopmentDrugEnergyFusionHumanMedtechProductScience
See relevant content for Entrepreneursfund.com
News
200
Portfolio
15
Mentions
19
Employees: 1-10

Portfolio 15

DateNameWebsiteTotal RaisedLocation
-Controlled...cpowert.com--
-n-Tecn-tec.no-Norway
-D3Od3o.com$37.07MUnited Kin...
-Vasopharmvasopharm.com$35.55MGermany, B...
-Fits.mefits.me$14.7M-
-Optinoseoptinose.com$165.5MUnited Sta...
-Organ Reco...organ-recovery.com-Belgium, B...
-SmartKem, ...smartkem.com$34.42MUnited Kin...
-Xerosxeroscleaning.com$14.92MUnited Kin...
-t2curet2cure.de--
Show more

News 200

DateTitleDescription
-Exosect receives UK patent for biopesticide formulationSeptember 10th, 2014 -- Winchester, UK – Exosect Ltd, a leading provider of enabling technologies, has received notification from the UK Patent Office that it has been granted a patent for the control of arthropod infestations in dry stored...
-CYTOO selected by DAIICHI SANKYOOctober 28th, 2015, Grenoble, France- CYTOO announces today that Daiichi Sankyo Company Limited, a Japanese pharmaceutical manufacturer with global presence, has selected CYTOO in vitro muscle platform MyoScreen™ to develop a novel cell-bas...
-vasopharm Reports Endorsement of Phase III Trial Design in Traumatic Brain Injury by European Medicines AgencyThe EMA’s Committee for Medicinal Products for Human Use (CHMP) has agreed to all major items of vasopharm’s proposed protocol for the realisation of a European Phase III study of VAS203 in patients suffering from traumatic brain injury (TB...
-Lifeline Scientific awarded NIH grant for tissue preservationLifeline Scientific (AIM: LSIC), the transplantation technology company, announces that Tissue Testing Technologies LLC ("T3"), a strategic affiliate, 49% of which is owned by Lifeline, has been awarded three new grants totaling U...
-General Fusion Brings in More Large Global InvestorsVANCOUVER, Canada: General Fusion announced today that it has closed additional financing in support of its Fusion Demonstration Plant (FDP) program. Highlighting this new financing are two more globally recognized institutional investors, ...
-Leila Karmali and Mario Alberto Accardi join Entrepreneurs Fund-
-General Fusion Appoints New ExecutivesVANCOUVER, CANADA – Clean energy leader General Fusion is enhancing the company’s design engineering capabilities and strategic partnerships with new leadership from veteran energy industry experts. The move comes as the company begins to t...
-Evolva announces collaboration with L’OréalThis collaboration will begin immediately and conclude in late 2016, and includes an option to expand the ingredient focus. L’Oréal will pay Evolva research fees during the project period. Additionally, Evolva is eligible to receive milesto...
-Prosonix and Mylan Enter Into Global Licensing Agreement for Generic Versions of Inhaled Respiratory Products Flixotide® and FloventPSX1001 and PSX1050, which are the first products to emerge from Prosonix’s innovative and proprietary particle engineering platform, are being developed as generic versions to GlaxoSmithKline’s pressurised metered dose inhalers (pMDI) Flix...
-Agreement signed with Eastern Laundry Systems in USXeros has signed an agreement with Eastern Laundry Systems Inc ('ELS'). ELS has been granted the exclusive rights to take over the servicing of Xeros' commercial laundry customers in nine states across the East Coast of the US, including Ne...
Show more

Mentions in press and media 19

DateTitleDescription
21.01.2016Daily funding roundup - January 21, 2016Canvs secured $5.6M; KTB Network led $4.5M funding for Qeexo; Arrayent landed additional $4M funding Arrayent announced that it has raised an additional $4 million in Series C funding from ORIX Ventures, adding to the initial $11 million it...
23.10.2015Daily funding roundup - October 23, 2015Sunnova Energy secured $300M; Playful raised $25M; Sequana Medical landed $9.3M Gurgaon-based foodtech startup, Leaping Caravan, has raised $150,000 in funding from a group of angel investors. The raised funding will be used for business ex...
23.10.2015Sequana Medical AG raises CHF 9 million
07.10.2015Daily funding roundup - October 7, 2015AppDirect raised $140M; CampoRico Fertilizers secured $40M; OptiNose nabbed $30M TNI medical AG, a Würzburg, Germany-based medical device company, raised €3 million ($3.36 million) in venture capital funding. Pathena Fund made the investmen...
23.10.2014Virtual fitting room solutions provider Fits.me receives €4.2m from CEO and existing investors in management buy-inVirtual fitting room solutions provider Fits.me has completed a first close of €4.2m [$5.34m] of a €7m 'top-up' investment from its new chief executive, James B. Gambrell, backed by its major investors. The management buy-in comprises new m...
15.08.2014SmartKem Completes Series A FundingSmartKem, a UK-based developer of semiconductor materials for displays and electronics, completed a Series A funding of undisclosed amount. Backers included BASF Venture Capital, Octopus Investments, Entrepreneurs Fund and Finance Wales. Th...
11.06.2014Virtual fitting room company Fits.me appoints chief executive to drive expansion and growthLondon, UK – June 11th 2014 – Fits.me, the leading virtual fitting room solutions provider, has appointed a new chief executive, James Gambrell, to expand the company into a global solutions provider for the world’s top apparel retailers. H...
28.04.2014Sequana Medical Raises CHF23M in Series C FinancingSequana Medical AG, a Zurich, Switzerland-based medical device company with innovative fluid management technologies, has raised CHF23m ($26.2m) in a Series C financing. The round was led by LSP (Life Science Partners), and co-led by NeoMed...
07.01.2014Incubator with six venture-backed spinouts seeks 2014 exit, unveils new sepsis spinoutThe six venture-backed spinouts include: Baronova, a startup trying for weight loss devices that are both non-surgical and non-pharma. The company closed a $27.3 million Series C round in February 2013, which was led by Boston Scientific (B...
03.07.2013Intranasal drug delivery disruptor OptiNose signs licensing deal for migraine treatmentA company that’s poised to disrupt the nasal drug delivery market has signed a licensing deal with Avanir Pharmaceuticals (Nasdaq: AVNR) valued at $110 million. OptiNose’s drug delivery system in Phase 3 development to treat migraine headac...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In